Motorcar Parts of America Reports Results for Fiscal Third Quarter and Nine Months
– Record Sales for Nine Months; Operating Income Up Sharply; Strong Cash Flow –
Key highlights for the fiscal third quarter.
-
Net sales increased 13.2 percent to
$171.9 million . - Gross margin improved by 3.7 percentage points.
-
Gross profit increased 43.1 percent to
$30.0 million . -
Operating income increased 170.1 percent to
$9.5 million . -
The company generated cash of approximately
$53.6 million .
Net sales for the fiscal 2024 third quarter increased 13.2 percent to
Gross profit for the fiscal 2024 third quarterincreased 43.1 percent to
Operating income for the fiscal 2024 third quarter increased 170.1 percent to
Interest expense for the fiscal third quarter increased by
Due primarily to
The company generated approximately
“Our year-to-date results reflect significant progress in achieving three major initiatives: increasing cash flow from profits and neutralizing working capital, and increasing sales and profitability, despite some unexpected softness throughout the industry in November and December. Our brake-related product categories continue to gain momentum, and we expect to realize ongoing improvements in operational efficiencies as volume further increases. Finally, we remain focused on executing our strategic plans and leveraging our leadership position,” said
Nine-Month Results
Net sales for the fiscal 2024 nine-month period increased 8.2 percent to a record
Gross profit for the fiscal 2024 nine-month period increased 25.6 percent to
Operating income for the fiscal 2024 nine-month period increased 166.7 percent to
Interest expense increased by
Due primarily to
Further Considerations
-
Sales volume continuing to gain momentum.
- Ordering activity expected to benefit from current extreme weather conditions.
- Industry fundamentals continue to drive product demand.
-
Margin improvement.
- Enhanced by multiple rounds of price increases.
- Improving overhead absorption as brake-related business gains further momentum.
- Improving operational efficiencies through volume increases.
- Enhanced cash flow from working capital initiatives.
Use of Non-GAAP Measure
This press release includes the following non-GAAP measure – EBITDA, which is not a measure of financial performance under GAAP and should not be considered as an alternative to net income as a measure of financial performance. The company believes this non-GAAP measure, when considered together with the corresponding GAAP measures, provides useful information to investors and management regarding financial and business trends relating to the company’s results of operations. However, this non-GAAP measure has significant limitations in that it does not reflect all the costs and other items associated with the operation of the company’s business as determined in accordance with GAAP. In addition, the company’s non-GAAP measures may be calculated differently and are therefore not comparable to similar measures by other companies. Therefore, investors should consider non-GAAP measures in addition to, and not as a substitute for, or superior to, measures of financial performance in accordance with GAAP. For a definition and reconciliation of EBITDA to net income, its corresponding GAAP measure, see the financial tables included in this press release. Also, refer to our Form 8-K to which this release is attached, and other filings we make with the
Earnings Conference Call and Webcast
About
The Private Securities Litigation Reform Act of 1995 provides a “safe harbor” for certain forward-looking statements. The statements contained in this press release that are not historical facts are forward-looking statements based on the company’s current expectations and beliefs concerning future developments and their potential effects on the company. These forward-looking statements involve significant risks and uncertainties (some of which are beyond the control of the company) and are subject to change based upon various factors. Reference is also made to the Risk Factors set forth in the company’s Form 10-K Annual Report filed with the
(Financial tables follow)
Consolidated Statements of Operations (Unaudited) |
||||||||
Three Months Ended |
|
Nine Months Ended |
||||||
|
|
|
||||||
2023 |
|
2022 |
|
2023 |
|
2022 |
||
Net sales |
|
|
|
|
||||
Cost of goods sold |
141,819,000 |
130,826,000 |
430,448,000 |
410,536,000 |
||||
Gross profit |
30,043,000 |
20,993,000 |
97,758,000 |
77,811,000 |
||||
Operating expenses: | ||||||||
General and administrative |
15,198,000 |
13,599,000 |
42,125,000 |
42,079,000 |
||||
Sales and marketing |
5,931,000 |
5,634,000 |
17,038,000 |
17,242,000 |
||||
Research and development |
2,539,000 |
2,547,000 |
7,352,000 |
8,330,000 |
||||
Foreign exchange impact of lease liabilities and forward contracts |
(3,149,000) |
(4,313,000) |
(2,659,000) |
(2,553,000) |
||||
Total operating expenses |
20,519,000 |
17,467,000 |
63,856,000 |
65,098,000 |
||||
Operating income |
9,524,000 |
3,526,000 |
33,902,000 |
12,713,000 |
||||
Other expenses: | ||||||||
Interest expense, net |
18,297,000 |
11,471,000 |
45,400,000 |
27,675,000 |
||||
Change in fair value of compound net derivative liability |
1,160,000 |
- |
1,690,000 |
- |
||||
Loss on extinguishment of debt |
- |
- |
168,000 |
- |
||||
Total other expenses |
19,457,000 |
11,471,000 |
47,258,000 |
27,675,000 |
||||
Loss before income tax expense (benefit) |
(9,933,000) |
(7,945,000) |
(13,356,000) |
(14,962,000) |
||||
Income tax expense (benefit) |
37,281,000 |
(8,971,000) |
37,226,000 |
(9,296,000) |
||||
Net (loss) income |
|
|
|
|
||||
Basic net (loss) income per share |
|
|
|
|
||||
Diluted net (loss) income per share |
|
|
|
|
||||
Weighted average number of shares outstanding: | ||||||||
Basic |
19,634,306 |
19,474,871 |
19,580,960 |
19,383,531 |
||||
Diluted |
19,634,306 |
19,634,153 |
19,580,960 |
19,383,531 |
Consolidated Balance Sheets |
||||
|
|
|||
ASSETS | (Unaudited) | |||
Current assets: | ||||
Cash and cash equivalents |
|
|
||
Short-term investments |
2,206,000 |
2,011,000 |
||
Accounts receivable — net |
93,008,000 |
119,868,000 |
||
Inventory |
393,777,000 |
356,254,000 |
||
Contract assets |
25,236,000 |
25,443,000 |
||
Prepaid expenses and other current assets |
17,978,000 |
22,306,000 |
||
Total current assets |
544,360,000 |
537,478,000 |
||
Plant and equipment — net |
39,644,000 |
46,052,000 |
||
Operating lease assets |
85,187,000 |
87,619,000 |
||
Long-term deferred income taxes |
2,447,000 |
32,625,000 |
||
Long-term contract assets |
318,323,000 |
318,381,000 |
||
|
4,461,000 |
5,348,000 |
||
Other assets |
1,511,000 |
1,062,000 |
||
TOTAL ASSETS |
|
|
||
LIABILITIES AND SHAREHOLDERS' EQUITY | ||||
Current liabilities: | ||||
Accounts payable and accrued liabilities |
|
|
||
Customer finished goods returns accrual |
37,883,000 |
37,984,000 |
||
Contract liabilities |
43,848,000 |
40,340,000 |
||
Revolving loan |
115,000,000 |
145,200,000 |
||
Other current liabilities |
5,369,000 |
4,871,000 |
||
Operating lease liabilities |
8,564,000 |
8,767,000 |
||
Current portion of term loan |
- |
3,664,000 |
||
Total current liabilities |
389,545,000 |
382,592,000 |
||
Term loan, less current portion |
- |
9,279,000 |
||
Convertible notes, related party |
33,226,000 |
30,994,000 |
||
Long-term contract liabilities |
206,590,000 |
193,606,000 |
||
Long-term deferred income taxes |
74,000 |
718,000 |
||
Long-term operating lease liabilities |
73,725,000 |
79,318,000 |
||
Other liabilities |
11,021,000 |
11,583,000 |
||
Total liabilities |
714,181,000 |
708,090,000 |
||
Commitments and contingencies | ||||
Shareholders' equity: | ||||
Preferred stock; par value |
- |
- |
||
Series A junior participating preferred stock; par value |
||||
20,000 shares authorized; none issued |
- |
- |
||
Common stock; par value |
||||
19,662,380 and 19,494,615 shares issued and outstanding at |
||||
|
197,000 |
195,000 |
||
Additional paid-in capital |
235,823,000 |
231,836,000 |
||
Retained earnings |
38,165,000 |
88,747,000 |
||
Accumulated other comprehensive income (loss) |
7,567,000 |
(303,000) |
||
Total shareholders' equity |
281,752,000 |
320,475,000 |
||
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY |
|
|
Additional Information and Non-GAAP Financial Measures
To supplement the consolidated financial statements presented in accordance with
The company believes this information helps provide a more complete understanding of the company's results of operations and the factors and trends affecting the company's business. However, this information should be considered as a supplement to, and not as a substitute for, or superior to, information contained in the company’s financial statements prepared in accordance with GAAP. In addition, the company’s non-GAAP measures may be calculated differently and are therefore not comparable to similar measures by other companies.
The company defines EBITDA as earnings before interest, taxes, depreciation, and amortization. A reconciliation of EBITDA to net income is provided below along with information regarding such items.
Items Impacting Net Income for the Three Months Ended |
Exhibit 1 |
||||||
Three Months Ended |
|||||||
2023 |
|
2022 |
|||||
$ |
|
Per Share |
|
$ |
|
Per Share |
|
GAAP net (loss) income |
|
|
|
|
|||
Non-cash items impacting net (loss) income | |||||||
Core and finished goods premium amortization |
|
|
|
|
|||
Revaluation - cores on customers' shelves |
1,607,000 |
0.08 |
863,000 |
0.04 |
|||
Share-based compensation expenses |
1,425,000 |
0.07 |
1,021,000 |
0.05 |
|||
Foreign exchange impact of lease liabilities and forward contracts |
(3,149,000) |
(0.16) |
(4,313,000) |
(0.22) |
|||
Change in fair value of compound net derivative liability |
1,160,000 |
0.06 |
- |
- |
|||
Tax effect (a) |
(970,000) |
(0.05) |
(162,000) |
(0.01) |
|||
Tax valuation allowance |
37,461,000 |
1.91 |
- |
- |
|||
Total non-cash items impacting net (loss) income |
|
|
|
|
|||
Cash items impacting net (loss) income | |||||||
Supply chain disruptions and related costs (b) |
|
|
|
|
|||
New product line start-up costs and transition expenses, and severance (c) |
296,000 |
0.02 |
1,103,000 |
0.06 |
|||
Tax effect (a) |
(463,000) |
(0.02) |
(938,000) |
(0.05) |
|||
Total cash items impacting net (loss) income |
|
|
|
|
(a) |
Tax effect is calculated by applying an income tax rate of 25.0% to items listed above; this rate may differ from the period's actual income tax rate. |
|
(b) |
For the three-months ended |
|
|
For the three-months ended |
|
(c) |
For the three-months ended |
|
|
For the three-months ended |
Items Impacting Net Income for the Nine Months Ended |
Exhibit 2 |
||||||
Nine Months Ended |
|||||||
2023 |
|
2022 |
|||||
$ |
|
Per Share |
|
$ |
|
Per Share |
|
GAAP net loss |
|
|
|
|
|||
Non-cash items impacting net loss | |||||||
Core and finished goods premium amortization |
|
|
|
|
|||
Revaluation - cores on customers' shelves |
4,380,000 |
0.22 |
2,704,000 |
0.14 |
|||
Share-based compensation expenses |
4,268,000 |
0.22 |
3,521,000 |
0.18 |
|||
Foreign exchange impact of lease liabilities and forward contracts |
(2,659,000) |
(0.14) |
(2,553,000) |
(0.13) |
|||
Change in fair value of compound net derivative liability and loss on extinguishment of debt |
1,858,000 |
0.09 |
- |
- |
|||
Tax effect (a) |
(4,012,000) |
(0.20) |
(3,214,000) |
(0.17) |
|||
Tax valuation allowance |
37,461,000 |
1.91 |
- |
- |
|||
Total non-cash items impacting net loss |
|
|
|
|
|||
Cash items impacting net loss | |||||||
Supply chain disruptions and related costs (b) |
|
|
|
|
|||
New product line start-up costs and transition expenses, and severance (c) |
980,000 |
0.05 |
2,642,000 |
0.14 |
|||
Tax effect (a) |
(1,930,000) |
(0.10) |
(3,151,000) |
(0.16) |
|||
Total cash items impacting net loss |
|
|
|
|
(a) |
Tax effect is calculated by applying an income tax rate of 25.0% to items listed above; this rate may differ from the period's actual income tax rate. |
|
(b) |
For the nine-months ended |
|
|
For the nine-months ended |
|
(c) |
For the nine-months ended |
|
|
For the nine-months ended |
Items Impacting Gross Profit for the Three Months Ended |
Exhibit 3 |
||||||
Three Months Ended |
|||||||
2023 |
|
2022 |
|||||
$ |
|
Gross Margin |
|
$ |
|
Gross Margin |
|
GAAP gross profit |
|
17.5% |
|
13.8% |
|||
Non-cash items impacting gross profit | |||||||
Core and finished goods premium amortization |
|
1.7% |
|
2.0% |
|||
Revaluation - cores on customers' shelves |
1,607,000 |
0.9% |
863,000 |
0.6% |
|||
Total non-cash items impacting gross profit |
|
2.6% |
|
2.6% |
|||
Cash items impacting gross profit | |||||||
Supply chain disruptions and related costs |
|
0.9% |
|
1.6% |
|||
Total cash items impacting gross profit |
|
0.9% |
|
1.6% |
Items Impacting Gross Profit for the Nine Months Ended |
Exhibit 4 |
||||||
Nine Months Ended |
|||||||
2023 |
|
2022 |
|||||
$ |
|
Gross Margin |
|
$ |
|
Gross Margin |
|
GAAP gross profit |
|
18.5% |
|
15.9% |
|||
Non-cash items impacting gross profit | |||||||
Core and finished goods premium amortization |
|
1.6% |
|
1.9% |
|||
Revaluation - cores on customers' shelves |
4,380,000 |
0.8% |
2,704,000 |
0.6% |
|||
Total non-cash items impacting gross profit |
|
2.4% |
|
2.4% |
|||
Cash items impacting gross profit | |||||||
Supply chain disruptions and related costs |
|
1.3% |
|
1.8% |
|||
Total cash items impacting gross profit |
|
1.3% |
|
1.8% |
Items Impacting EBITDA for the Three and Nine Months Ended |
Exhibit 5 |
||||||
Three Months Ended |
|
Nine Months Ended |
|||||
2023 |
|
2022 |
|
2023 |
|
2022 |
|
GAAP net (loss) income |
|
|
|
|
|||
Interest expense, net |
18,297,000 |
11,471,000 |
45,400,000 |
27,675,000 |
|||
Income tax expense (benefit) |
37,281,000 |
(8,971,000) |
37,226,000 |
(9,296,000) |
|||
Depreciation and amortization |
2,878,000 |
3,108,000 |
8,844,000 |
9,322,000 |
|||
EBITDA |
|
|
|
|
|||
Non-cash items impacting EBITDA | |||||||
Core and finished goods premium amortization |
|
|
|
|
|||
Revaluation - cores on customers' shelves |
1,607,000 |
863,000 |
4,380,000 |
2,704,000 |
|||
Share-based compensation expenses |
1,425,000 |
1,021,000 |
4,268,000 |
3,521,000 |
|||
Foreign exchange impact of lease liabilities and forward contracts |
(3,149,000) |
(4,313,000) |
(2,659,000) |
(2,553,000) |
|||
Change in fair value of compound net derivative liability and loss on extinguishment of debt |
1,160,000 |
- |
1,858,000 |
- |
|||
Total non-cash items impacting EBITDA |
|
|
|
|
|||
Cash items impacting EBITDA | |||||||
Supply chain disruptions and related costs |
|
|
|
|
|||
New product line start-up costs and transition expenses, and severance |
296,000 |
1,103,000 |
980,000 |
2,642,000 |
|||
Total cash items impacting EBITDA |
|
|
|
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20240209672412/en/
Vice President,
(310) 972-5124
Source: